Hillsdale Investment Management Inc. increased its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 46.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,020 shares of the company’s stock after purchasing an additional 1,920 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Express Scripts were worth $382,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of ESRX. Burt Wealth Advisors boosted its stake in Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the last quarter. CKW Financial Group boosted its stake in Express Scripts by 20.0% during the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Express Scripts by 8.1% during the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after buying an additional 145 shares during the last quarter. FNY Partners Fund LP acquired a new position in Express Scripts during the first quarter worth $138,000. Finally, First Personal Financial Services boosted its stake in Express Scripts by 199.1% during the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after buying an additional 1,400 shares during the last quarter. Hedge funds and other institutional investors own 88.44% of the company’s stock.
In related news, CEO Timothy C. Wentworth purchased 8,000 shares of the business’s stock in a transaction on Tuesday, October 31st. The shares were bought at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the acquisition, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.
ESRX has been the topic of several recent analyst reports. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Jefferies Group set a $72.00 price target on Express Scripts and gave the company a “buy” rating in a research note on Tuesday, August 29th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research note on Monday, October 16th. Finally, Deutsche Bank initiated coverage on Express Scripts in a research note on Monday, December 4th. They issued a “buy” rating and a $75.00 price target on the stock. Six investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $70.67.
Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at $68.15 on Monday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $38,598.32, a price-to-earnings ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88. Express Scripts Holding Company has a 1-year low of $55.80 and a 1-year high of $73.52.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the previous year, the business earned $1.74 EPS. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. research analysts forecast that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.
WARNING: “Express Scripts Holding Company (NASDAQ:ESRX) Shares Bought by Hillsdale Investment Management Inc.” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://ledgergazette.com/2017/12/11/express-scripts-holding-company-esrx-position-increased-by-hillsdale-investment-management-inc.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.